Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon signing of the first clinical site.
The company was granted U.S. Patent No. 9,598,673, which covers the use of any mesenchymal stem cells, both autologous or allogeneic, for reduction of lower back pain when injected into the major muscles of the lower back.
Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon...
Creative Medical Technology started recruitment of clinical sites for StemSpine®, a regenerative stem cell procedure for the treatment of degenerative disc disease.
The company will seek out locations across the U.S., geographically dispersed to provide maximum access to potential patients. Patient recruitment will begin immediately upon signing of the first clinical site.
The company was granted U.S. Patent No. 9,598,673, which covers the use of any mesenchymal stem cells, both autologous or allogeneic, for reduction of lower back pain when injected into the major muscles of the lower back.
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
Copy to clipboard 
